Search Browse Earnings

Verrica Pharmaceuticals Inc.

Nasdaq:VRCA

Pharmaceutical Preparations·WEST CHESTER, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Verrica Pharmaceuticals Inc. — SlamSEC

Revenue

$5.1M

-43.3% YoY

FY 2024

Adj. EBITDA

-$65.2M

-1273.0% margin

FY 2024

Net Income

-$67.0M

-1307.5% margin

FY 2024

EPS (Diluted)

-$1.48

FY 2024

Stock Price

$5.71

+7.9%

2026-03-09

52W Range

$3.28 – $9.82

P/E Ratio

-3.9x

Market Cap

$54.2M

Cash

$69.5M

FY 2024

Total Debt

$78.2M

FY 2024

Net Debt

$8.6M

FY 2024

Enterprise Value

$62.8M

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

-1.0x

Employees

—